TUESDAY, AUGUST 21
DINNER, 6:45 - 9:15 PM
SC6: RAPID DIAGNOSTICS FOR ANTIMICROBIAL STEWARDSHIP
Instructors:
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California
April Abbott, PhD, D(ABMM), Director, Microbiology, Deaconess Health System
Amanda Harrington, PhD, Associate Professor, Pathology; Medical Director, Microbiology, Loyola University Medical Center
Arlington
Course Description:
In recent years, emerging technologies have expedited the reporting of susceptibility results directly from clinical specimens. Approaches to rapid phenotypic and genotypic susceptibilities testing will be provided. Cases will be used to illustrate the benefits and pitfalls of genotypic and phenotypic susceptibility testing. Implementation and interpretation of susceptibility results to maximize clinical impact will be discussed.
Course Outline:
Rapid Genotypic Susceptibility Testing of Bacteria
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California
Rapid Phenotypic Susceptibility Testing of Bacteria
Amanda Harrington, PhD, Associate Professor, Pathology; Medical Director, Microbiology, Loyola University Medical Center
Application of Rapid Susceptibility Testing in the Clinical Setting
April Abbott, PhD, D(ABMM), Director, Microbiology, Deaconess Health System
Instructor Biographies:
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California
Dr. Jennifer Dien Bard is the director of the clinical microbiology and virology laboratories at Children’s Hospital Los Angeles (CHLA) and Associate Professor of Pathology and Clinical Scholar at the University of Southern California Keck School of Medicine. Dr. Dien Bard is a Diplomate of the American Board of Medical Microbiology and a Fellow of the Canadian College of Microbiologists. Her current research interests include the development and utilization of rapid laboratory diagnostics and their subsequent impact on patient management.
April Abbott, PhD, D(ABMM), Director, Microbiology, Deaconess Health System
Dr. Abbott is the Microbiology Director at Deaconess Health System and an adjunct faculty member of Indiana University School of Medicine in Evansville, Indiana. She obtained her Ph.D. from the University of Texas at Houston and then did a clinical post-doctoral fellowship at the University of Washington in Seattle. Dr. Abbott is a Diplomate of the American Board of Medical Microbiology. She is a member of the CLSI Subcommittee for Antimicrobial Susceptibility Testing and speaks nationally on the topic of antimicrobial susceptibility testing. She has co-authored book chapters on the topics of susceptibility testing and resistance mechanisms in the Manual of Clinical Microbiology and Tietz Textbook of Clinical Chemistry and Molecular Diagnostics.
Amanda Harrington, PhD, Associate Professor, Pathology; Medical Director, Microbiology, Loyola University Medical Center
Dr. Amanda Harrington is the director of the clinical microbiology laboratory at Loyola University Medical Center and Associate Professor of Pathology and Laboratory Medicine at Loyola University Chicago. Dr. Harrington is a Diplomate of the American Board of Medical Microbiology and the President-Elect fof the Illinois Society for Microbiology. As a member of ASM, she is an editorial board member for the Journal of Clinical Microbiology and a member of the Committee on Postgraduate Educational Programs. Her research interests include rapid diagnostic and molecular-based testing and metrics based assessment of quality in clinical microbiology and infectious diseases.